NIO Inc. (NYSE: NIO) on Tuesday reported a narrower loss for the second quarter of 2025, on an adjusted basis, reflecting an increase in vehicle sales. The company also issued positive guidance for the third quarter.
The China-based electric car maker’s revenues increased 9% year-over-year to $2.65 billion in the second quarter of fiscal 2025. Vehicle sales, the primary revenue source, increased 2.9% YoY.
Net loss attributable to Nio shareholders was $717.7 million or $0.32 per ADS in the June quarter. Excluding share-based compensation expenses, organizational optimization charges and accretion on redeemable non-controlling interests to redemption value, adjusted net loss per ADS came in at $0.25, compared to a loss of $0.30 per ADS last year.
For the third quarter of 2025, the company expects total revenues to be between $3.045 billion and $3.193 billion. It forecasts total vehicle deliveries in the range of 87,000 to 91,000 for Q3.
William Bin Li, CEO of NIO, said, “The strong market reception of ONVO L90 and NIO All-New ES8 has reinforced our overall sales momentum. Driven by this strong demand, we anticipate total deliveries in the third quarter to range between 87,000 and 91,000, representing a year-on-year growth of 40.7% to 47.1% and setting a new Company record.”
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
